J&J Earnings Beat: Why Did the Stock Still Fall?
Earnings Beat, Shares Down: What Spooked J&J Investors? Key Takeaways Earnings Beat with a Twist: Johnson & Johnson reported Q4 2025 sales of $24.6 billion, exceeding estimates by about 1.7%, and adjusted EPS of $2.46, roughly in line with expectations, but the stock dipped around 1-2% post-earnings due to specific concerns. Optimistic Outlook Amid Challenges: […]
J&J Earnings Beat: Why Did the Stock Still Fall? Read More »









